Targacept.

PositionRegional Report - Completed a $60 million second round of financing - Brief Article

Targacept, which searches for medical uses for nicotine, completed a $60 million second round of financing. Investors include Boston-based Oxford Bioscience Partners and Houston-based Cogene Biotech Ventures. The money will be used to develop drugs to treat...

To continue reading

Request your trial

VLEX uses login cookies to provide you with a better browsing experience. If you click on 'Accept' or continue browsing this site we consider that you accept our cookie policy. ACCEPT